Pemetrexed(P) in Third and Fourth Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (Non-Squamous)-aNSCLCns

被引：0
|
作者：
Grigorescu, Alexandru Calin [1 ]
Ilie, Dan [2 ]
机构：
[1] Inst Oncol Bucharest, Med Oncol Li, Bucharest, Romania
[2] Inst Oncol Bucharest, Bucharest, Romania
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Advanced Nonsmall-Cell lung Cancer; chemotherapy; Third line chemotherapy;
D O I：
10.1016/j.jtho.2016.11.1276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03a-066
引用
收藏
页码：S929 / S929
页数：1
相关论文
共 50 条
  • [21] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
    Grossi, F.
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Burrafato, G.
    Sini, C.
    Dal Bello, M. G.
    Meyer, K.
    Roder, J.
    Roder, H.
    Grigorieva, J.
    BRITISH JOURNAL OF CANCER, 2017, 116 (01) : 36 - 43
  • [23] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] EFFICIENCY OF CISPLATIN, PEMETREXED, AND BEVACIZUMAB AS FIRST-LINE TREATMENT FOR JAPANESE ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS
    Shiraishi, Yoshimasa
    Hirai, Humihiko
    Yamaguchi, Masafumi
    Morodomi, Yosuke
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Takenaka, Tomoyoshi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
  • [26] PEMETREXED AS FIRST-LINE TREATMENT IN COMBINATION WITH EARLY RADIOTHERAPY IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE ANALYSIS
    Cai, Xuwei
    Zhang, Qin
    Yu, Wen
    Liu, Qi
    Fan, Min
    Feng, Wen
    Zhao, Weixin
    Fu, Xiaolong
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S554 - S554
  • [27] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Pemetrexed in the treatment of advanced non-squamous lung cancer
    Rossi, Antonio
    Ricciardi, Serena
    Maione, Paolo
    de Marinis, Filippo
    Gridelli, Cesare
    LUNG CANCER, 2009, 66 (02) : 141 - 149
  • [29] The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Tucker, Steven
    CURRENT DRUG TARGETS, 2010, 11 (01) : 58 - 60
  • [30] Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan
    Asami, Kazuhiro
    Kawahara, Masaaki
    Hirashima, Tomonori
    Suzuki, Hidekazu
    Okishio, Kyoichi
    Omachi, Naoki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Hirooka, Aya
    Nakao, Keiko
    Tsuji, Taisuke
    Atagi, Shinji
    THORACIC CANCER, 2014, 5 (04) : 289 - 296
12345